MIA's Autumn Newsletter
12 April 2015
The latest news and information from MIA can be read in our Autumn newsletter which can be downloaded here.
5 minutes with Associate Professor Georgina Long
As 2015 draws to a close, we took the opportunity to speak with Associate Professor Georgina Long to discuss her crucial role at Melanoma Institute Australia, and the current research projects she is working on.
Watch Your Mate's Back: helping young Australians recognise melanoma
MIA’s annual summer awareness campaign, which launched today (1 December), is reminding Australians how to protect themselves from the sun while highlighting the importance of encouraging friends, partners and family to do the same.
Your Guide to Early Melanoma patient information packs
Your Guide to Early Melanoma is a new patient information pack to offer additional information for those affected by melanoma.
Clinicians invited to MIA's 'World Round Up' event
Special Event to share advances in diagnosis and treatment of both early and late stage melanoma
Melanoma landmark study to help further develop personalised cancer treatment
MIA researchers contribute to the discovery of ‘treasure trove’ of information leading to more targeted treatments for melanoma
Sunrise features inspiring story of MIA patient
Melanoma Institute Australia (MIA) patient Tara Moran and her seven year old daughter Olivia, who is fundraising for MIA, have been in the national media spotlight this week.
Leading researchers honoured for global contribution to science and innovation
Melanoma Institute Australia’s (MIA’s) researchers have again been recognised, this time in the prestigious line-up for the 2015 Thomson Reuters Australian Citation & Innovation Awards.
MIA welcomes ground-breaking new PBS melanoma treatment
New Federal Government funding means patients with the most deadly form of melanoma, will soon be able to receive treatment with the drug Keytruda® (pembrolizumab), on the Pharmaceutical Benefits Scheme (PBS).
MIA contributes to major research breakthrough which pioneers a new way of treating cancer
The best ever results seen in metastatic melanoma treatment have been presented at the International ASCO Conference.
Q&A with our Clinical Research Fellow
We sat down for a short Q&A with our Clinical Research Fellow Sangeetha Ramanujam.
International Clinical Trials Day marked
Today marks International Clinical Trials Day held on May 20 each year celebrating how far clinicians have come in the field of research.
5 minutes with Practice Manager Sherrie D'Souza
We sat down with MIA Practice Manager, Sherrie D'Souza and got an insight into the day of life of her role.
Associate Professor Georgina Long has won the InStyle Women In Style Award
Dr Long was nomitated for the InStyle Women In Style Awards in the Science and Environment category.
The Federal Government's 2015-16 Budget announcements benefit research
The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding.
Professor Thompson made an honorary member of the American Surgical Association
The Association's members include prominent surgeons from around the world.
MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients
This is a landmark study, the first in a class of drugs that will change the future of treatment for all cancers.
Anti-PD1 immunotherapy pembrolizumab (KEYTRUDA® ) has been registered by the TGA
Australia is the first country in the world to register anti-PD1 for the first line treatment of unresectable or metastatic melanoma in adults.
MIA's Autumn Newsletter
Our Autumn newsletter has been published and we have our digital version online now.
Professor John Thompson appointed to Australian Academy of Health and Medical Sciences
Professor John Thompson, Executive Director at Melanoma Institute Australia, was one of 116 fellows appointed to the new Australian Academy of Health and Medical Sciences at a ceremony in Canberra on the 25th March.